ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $19,000 | -17.4% | 7,778 | -21.4% | 0.00% | – |
| Q2 2020 | $23,000 | -14.8% | 9,899 | -3.8% | 0.00% | – |
| Q1 2020 | $27,000 | +92.9% | 10,293 | -13.3% | 0.00% | – |
| Q4 2019 | $14,000 | +7.7% | 11,876 | -4.7% | 0.00% | – |
| Q3 2019 | $13,000 | -40.9% | 12,461 | 0.0% | 0.00% | – |
| Q2 2019 | $22,000 | -56.0% | 12,461 | 0.0% | 0.00% | – |
| Q1 2019 | $50,000 | -37.5% | 12,461 | -58.9% | 0.00% | – |
| Q4 2018 | $80,000 | -54.8% | 30,303 | +25.6% | 0.00% | – |
| Q3 2018 | $177,000 | +4.7% | 24,119 | 0.0% | 0.00% | – |
| Q2 2018 | $169,000 | -18.0% | 24,119 | +8.5% | 0.00% | – |
| Q1 2018 | $206,000 | +151.2% | 22,233 | +105.3% | 0.00% | – |
| Q4 2017 | $82,000 | -29.3% | 10,828 | 0.0% | 0.00% | – |
| Q3 2017 | $116,000 | -1.7% | 10,828 | +4.5% | 0.00% | – |
| Q2 2017 | $118,000 | +18.0% | 10,359 | +11.2% | 0.00% | – |
| Q1 2017 | $100,000 | -7.4% | 9,316 | -1.5% | 0.00% | – |
| Q4 2016 | $108,000 | +58.8% | 9,454 | +62.1% | 0.00% | – |
| Q3 2016 | $68,000 | +7.9% | 5,834 | 0.0% | 0.00% | – |
| Q2 2016 | $63,000 | – | 5,834 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 5,118,560 | $14,025,000 | 1.27% |
| Ikarian Capital, LLC | 3,638,000 | $9,968,000 | 0.75% |
| Rubric Capital Management LP | 871,100 | $2,387,000 | 0.38% |
| Burrage Capital Management LLC | 135,898 | $363,000 | 0.36% |
| Soleus Capital Management, L.P. | 81,200 | $222,000 | 0.26% |
| Artal Group S.A. | 1,000,000 | $2,740,000 | 0.12% |
| BOOTHBAY FUND MANAGEMENT, LLC | 497,857 | $1,364,000 | 0.11% |
| Alambic Investment Management, L.P. | 10,700 | $29,000 | 0.07% |
| LORD, ABBETT & CO. LLC | 1,688,490 | $4,627,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 530,952 | $1,455,000 | 0.02% |